GastroenterologyNews.net

Gastroenterology Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "Ustekinumab"

In phase 3 studies of Ustekinumab ( Stelara ), a fully human monoclonal IL-12/23p40 antibody approved for moderate-to-severe Crohn's disease, patients entered a long-term extension after completing 8 ...